Cargando…
PIONEER trial: favipiravir to treat moderate COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750180/ https://www.ncbi.nlm.nih.gov/pubmed/36528037 http://dx.doi.org/10.1016/S2213-2600(22)00479-9 |
| _version_ | 1784850197402091520 |
|---|---|
| author | Shalhoub, Sarah |
| author_facet | Shalhoub, Sarah |
| author_sort | Shalhoub, Sarah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9750180 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97501802022-12-15 PIONEER trial: favipiravir to treat moderate COVID-19 Shalhoub, Sarah Lancet Respir Med Comment Elsevier Ltd. 2023-05 2022-12-14 /pmc/articles/PMC9750180/ /pubmed/36528037 http://dx.doi.org/10.1016/S2213-2600(22)00479-9 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Shalhoub, Sarah PIONEER trial: favipiravir to treat moderate COVID-19 |
| title | PIONEER trial: favipiravir to treat moderate COVID-19 |
| title_full | PIONEER trial: favipiravir to treat moderate COVID-19 |
| title_fullStr | PIONEER trial: favipiravir to treat moderate COVID-19 |
| title_full_unstemmed | PIONEER trial: favipiravir to treat moderate COVID-19 |
| title_short | PIONEER trial: favipiravir to treat moderate COVID-19 |
| title_sort | pioneer trial: favipiravir to treat moderate covid-19 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750180/ https://www.ncbi.nlm.nih.gov/pubmed/36528037 http://dx.doi.org/10.1016/S2213-2600(22)00479-9 |
| work_keys_str_mv | AT shalhoubsarah pioneertrialfavipiravirtotreatmoderatecovid19 |